Skip to content
HowShorted

VBI Vaccines, Inc. New short interest in 2020

In 2020, VBI Vaccines, Inc. New's disclosed short interest ran from 3.65% of shares outstanding on 15 Jan 2020 to 18.92% on 31 Dec 2020, a change of +15.27 percentage points. The year's high was 22.20% on 15 Oct 2020 and its low 3.39% on 31 Mar 2020, averaging 9.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.05 days on 30 Oct 2020. Full history: VBI Vaccines, Inc. New.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for VBI Vaccines, Inc. New in 2020

2020 in figures

Start of year
3.65% (15 Jan 2020)
End of year
18.92% (31 Dec 2020)
Change
+15.27 pp
High
22.20% (15 Oct 2020)
Low
3.39% (31 Mar 2020)
Average
9.36%
Highest days to cover
11.05 (30 Oct 2020)
SEC filings marked
8

Every report in 2020

VBI Vaccines, Inc. New short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20203.65%1.00
31 Jan 20203.42%1.19
14 Feb 20204.12%2.88
28 Feb 20203.94%2.42
13 Mar 20204.13%2.0810-K filed, results (8-K)
31 Mar 20203.39%2.98
15 Apr 20204.66%3.58
30 Apr 20205.03%1.00
15 May 20204.57%1.0010-Q filed, results (8-K)
29 May 20203.65%1.00
15 Jun 20207.86%1.85
30 Jun 20206.11%1.00
15 Jul 20206.03%1.00
31 Jul 20206.89%1.0010-Q filed
14 Aug 20207.13%1.61results (8-K)
31 Aug 20208.95%1.00
15 Sep 202010.03%2.74
30 Sep 202020.94%4.64
15 Oct 202022.20%9.02
30 Oct 202017.62%11.05
13 Nov 202016.90%6.2510-Q filed, results (8-K)
30 Nov 202017.26%7.30
15 Dec 202017.14%7.42
31 Dec 202018.92%7.21

See also: VBI Vaccines, Inc. New's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.